Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
253.88
+6.42 (+2.59%)
Streaming Delayed Price
Updated: 1:04 PM EDT, Sep 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
AI-Assisted Clinical Research Could Accelerate Personalized Medicine
↗
Today 5:55 EDT
The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion
Via
Talk Markets
Topics
Artificial Intelligence
3 Healthcare Stocks with Warning Signs
Today 0:33 EDT
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via
StockStory
Automated Labeling Tools Are Modernizing the AI Training Dataset Market
↗
September 18, 2026
The global AI training dataset market was valued at USD 3.2 billion in 2025 and is projected to reach USD 16.3 billion by 2033, expanding from USD 3.9 bill
Via
Talk Markets
Topics
Artificial Intelligence
1 Surging Stock to Target This Week and 2 We Question
September 17, 2026
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...
Via
StockStory
Illumina (NASDAQ:ILMN) Beats Q2 Estimates but Shares Slide 6% After-Hours
↗
July 30, 2026
Via
Chartmill
Illumina (NASDAQ:ILMN) Scores Perfect Technical Rating and High Setup Quality for Breakout Trade
↗
July 30, 2026
Via
Chartmill
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
↗
September 11, 2026
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
Via
Benzinga
Bloom Energy Is Joining the S&P 500: Is the Stock Still a Buy After Its Massive Run?
↗
September 08, 2026
Bloom Energy has secured a spot in the S&P 500 as part of its quarterly rebalancing.
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Stocks
Bloom Energy, Illumina, Everpure Rise On S&P 500 Inclusion
↗
September 04, 2026
The fuel-cell company will join on Sept. 21, along with Illumina and Everpure.
Via
Investor's Business Daily
Topics
Stocks
Saudi Arabia Internet of Medical Things Market 2031: AI, Wearables & Smart Medical Devices Drive Transformation
↗
September 04, 2026
Industry Key HighlightsThe Saudi Arabia IoMT Market is expected to increase from USD 289.34 million in 2025 to USD 676.63 million by 2031.The market is pro
Via
Talk Markets
Topics
Artificial Intelligence
The Market Just Told You Which Layer Of AI Biology It Is Paying For
September 03, 2026
Issued on behalf of MindWalk Holdings Corp.
From
Market Updates
Via
GlobeNewswire
3 High-Flying Stocks We Keep Off Our Radar
September 02, 2026
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...
Via
StockStory
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
↗
August 28, 2026
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized basis producing an average annual return of 13.55%. Currently, Illumina has a market capitalization...
Via
Benzinga
1 Large-Cap Stock with Competitive Advantages and 2 We Find Risky
August 28, 2026
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
Via
StockStory
Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks
August 25, 2026
Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and...
Via
StockStory
Topics
Artificial Intelligence
Precision Medicine Software Market: Companion Diagnostics Rise
↗
August 20, 2026
Precision medicine software has moved from a niche research tool to a core piece of modern healthcare infrastructure. As genomic sequencing gets cheaper an
Via
Talk Markets
Topics
Artificial Intelligence
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
August 17, 2026
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via
StockStory
Waters Q2 Earnings Call Highlights
↗
August 09, 2026
Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic...
Via
MarketBeat
Topics
Earnings
Biotech AI Retail Solutions Market to Reach USD 7.12 Billion by 2034
↗
August 07, 2026
According to a new report from Intel Market Research, the global Biotech AI Retail Solutions market was valued at USD 3.45 billion in 2025 and is projected
Via
Talk Markets
Topics
Artificial Intelligence
5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call
August 06, 2026
Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a...
Via
StockStory
Topics
Earnings
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
↗
August 05, 2026
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization...
Via
Benzinga
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
August 04, 2026
Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after market close. Here’s what to expect. 10x Genomics beat anal...
Via
StockStory
PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect
August 03, 2026
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday afternoon. Here’s what you need to know. PacBio mis...
Via
StockStory
Illumina (ILMN) Q2 2026 Earnings Call Transcript
↗
August 03, 2026
Clinical momentum and NovaSeq X placements drive revenue guidance raise.
Via
The Motley Fool
Topics
Earnings
3 Cash-Producing Stocks That Concern Us
August 03, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
↗
August 01, 2026
The developer of blood-based cancer tests still has a bright future.
Via
The Motley Fool
Illumina Q2 Earnings Call Highlights
↗
July 31, 2026
Illumina (NASDAQ:ILMN) raised its 2026 revenue and earnings outlook after reporting second-quarter results that exceeded its expectations, supported by clinical sequencing demand, elevated NovaSeq X...
Via
MarketBeat
Topics
Earnings
ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift
July 31, 2026
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s...
Via
StockStory
Illumina (ILMN) Q2 2026 Earnings Call Transcript
↗
July 30, 2026
Clinical momentum and NovaSeq X placements drive revenue guidance raise.
Via
The Motley Fool
Topics
Earnings
Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations
July 30, 2026
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. ...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today